PubRank

J J Thiessen

Author PubWeight™ 28.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 1996 2.35
2 Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res 1996 1.57
3 L-arginine transport in the human coronary and peripheral circulation. Circulation 2004 1.44
4 Diazepam actions and plasma concentrations following ethanol ingestion. Eur J Clin Pharmacol 1977 1.33
5 Plasma protein binding of diazepam and tolbutamide in chronic alcoholics. J Clin Pharmacol 1976 1.07
6 Cloxacillin absorption and disposition in cystic fibrosis. J Pediatr 1984 0.96
7 Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin. Cancer Res 1993 0.92
8 Aspirin: plasma concentration and effects. Thromb Res Suppl 1983 0.91
9 Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease. Clin Pharmacol Ther 1988 0.91
10 High-pressure liquid chromatographic analysis of indocyanine green. J Pharm Sci 1982 0.90
11 Human endothelin-1 clearance kinetics revealed by a radiotracer technique. J Pharmacol Exp Ther 1999 0.89
12 Ethanol vapor above skin: determination by a gas sensor instrument and relationship with plasma concentration. Alcohol Clin Exp Res 1987 0.85
13 Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin. Stroke 1980 0.85
14 Metoprolol kinetics and dose response in hypertensive patients. Clin Pharmacol Ther 1980 0.84
15 Gas chromatographic/mass spectrometric analysis of methylphenidate (ritalin) in serum. Clin Biochem 1980 0.84
16 Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid. Pediatrics 1983 0.83
17 Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis. J Pediatr 1985 0.83
18 Determinants of low serum concentrations of salicylates in patients with Kawasaki disease. J Pediatr 1988 0.82
19 Variability in the pharmacokinetics of cyclophosphamide, methotrexate and 5-fluorouracil in women receiving adjuvant treatment for breast cancer. Cancer Chemother Pharmacol 1994 0.82
20 Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks. J Clin Oncol 1998 0.80
21 A comparative clarithromycin bioavailability study: determination of clarithromycin and 14-(R)-hydroxyclarithromycin under fasting and fed conditions. Int J Clin Pharmacol Ther 2004 0.80
22 Rapid development of enhanced clearance after high-dose cyclophosphamide. Clin Pharmacol Ther 1988 0.80
23 Determination of fostriecin pharmacokinetics in plasma using high-pressure liquid chromatography assay. Ther Drug Monit 1994 0.80
24 Indocyanine green pharmacokinetics in the rabbit. Can J Physiol Pharmacol 1984 0.80
25 Challenges in comparing treatment outcome from a prospective with that of a retrospective study: assessing the merit of gentamicin therapeutic drug monitoring in pediatric oncology. Ther Drug Monit 1994 0.80
26 Transport kinetics of iron chelators and their chelates in Caco-2 cells. Pharm Res 2006 0.79
27 The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients. Pharmacotherapy 1996 0.79
28 High-performance liquid chromatographic analysis of amiloride in plasma and urine. J Chromatogr 1984 0.78
29 Disposition of total and free cisplatin on two consecutive treatment cycles in patients with ovarian cancer. Cancer Chemother Pharmacol 1987 0.78
30 Effect of PSC 833, a potent inhibitor of P-glycoprotein, on the growth of astrocytoma cells in vitro. Cancer Lett 2003 0.76
31 Mean time parameters reveal differences in the pharmacokinetics of indium-111 and iodine-131-labeled B72.3 monoclonal antibody. J Nucl Med 1992 0.75
32 Competitive binding of sulfamethazine and its N-acetylated metabolite. Biopharm Drug Dispos 1989 0.75
33 Ethanol vapours above lacrimal fluid in the rabbit. Can J Physiol Pharmacol 1987 0.75
34 Daily maintenance dose of a long-acting theophylline from a single theophylline serum level. Chest 1986 0.75
35 A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal cancer. Cancer Chemother Pharmacol 1995 0.75
36 Does thiopentone delay recovery in children premedicated with midazolam? Paediatr Anaesth 1997 0.75
37 Disposition of cyclophosphamide on two consecutive cycles of treatment in patients with ovarian carcinoma. Arzneimittelforschung 1988 0.75
38 Placental transfer of acetylsalicylic acid (ASA) and salicylic acid (SA) in near-term ewes. Prog Clin Biol Res 1983 0.75
39 Compartmental analysis of the pharmacokinetics of radioiodinated monoclonal antibody B72.3 in colon cancer patients. Nucl Med Biol 1993 0.75
40 Effect of alcohol on propylthiouracil disposition. Clin Pharmacol Ther 1983 0.75
41 Human platelet response to three salicylate dosage forms. Biopharm Drug Dispos 1983 0.75
42 High-performance liquid chromatographic assays for a second-generation novel oral iron chelator (APCP363) and their application to pharmacokinetic studies in rats. J Chromatogr B Biomed Sci Appl 2001 0.75
43 Valproic acid disposition in rabbits during chronic treatment with Escherichia coli endotoxin. Can J Physiol Pharmacol 1985 0.75
44 Placental drug transfer in near-term ewes: acetylsalicylic and salicylic acid. Can J Physiol Pharmacol 1984 0.75
45 Liquid chromatographic analysis of sulfaquinoxaline and its application to pharmacokinetic studies in rabbits. J Pharm Sci 1984 0.75
46 Pharmacokinetic and pharmacodynamic studies of 9-aminocamptothecin in vitro against human cancer cells. Ann N Y Acad Sci 1996 0.75
47 Development and validation of a limited sampling strategy for 5-fluorouracil given by bolus intravenous administration. Ther Drug Monit 1993 0.75
48 Relevance to redesigning aspirin therapeutic regimens. Thromb Res Suppl 1983 0.75
49 Kinetics of drug-drug interactions in sheep: tolbutamide and sulfadimethoxine. J Pharm Sci 1977 0.75